UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonviral delivery of self-amplifying RNA vaccines

Proceedings of the National Academy of Sciences - PNAS, 2012-09, Vol.109 (36), p.14604-14609

2012

Volltextzugriff (PDF)

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Molecular therapy, 2014-12, Vol.22 (12), p.2118-2129

2014

Volltextzugriff (PDF)

Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice

Vaccine, 2014-06, Vol.32 (30), p.3796-3804

2014

Volltextzugriff (PDF)

Optimized AAV Vectors for TMC1 Gene Therapy in a Humanized Mouse Model of DFNB7/11

Biomolecules (Basel, Switzerland), 2022-06, Vol.12 (7), p.914

2022

Volltextzugriff (PDF)

Control of alphavirus-based gene expression using engineered riboswitches

Virology (New York, N.Y.), 2015-09, Vol.483, p.302-311

2015

Volltextzugriff (PDF)

Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells

Molecular therapy, 2017-04, Vol.25 (4), p.949-961

2017

Volltextzugriff (PDF)

Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice

Molecular therapy, 2019-04, Vol.27 (4), p.850-865

2019

Volltextzugriff (PDF)

Ribosomal Protein S6 Associates with Alphavirus Nonstructural Protein 2 and Mediates Expression from Alphavirus Messages

Journal of Virology, 2006-08, Vol.80 (15), p.7729-7739

2006

Volltextzugriff (PDF)

Production of recombinant adeno-associated virus 5 using a novel self-attenuating adenovirus production platform

Molecular therapy. Methods & clinical development, 2024-09, Vol.32 (3), p.101320, Article 101320

2024

Volltextzugriff (PDF)

A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo

PLoS pathogens, 2007-12, Vol.3 (12), p.e199-e199

2007

Volltextzugriff (PDF)

Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity

Virology (New York, N.Y.), 2013-12, Vol.447 (1), p.254-264

2013

Volltextzugriff (PDF)

Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization

Vaccine, 2010-04, Vol.28 (18), p.3238-3246

2010

Volltextzugriff (PDF)

Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus

Journal of Virology, 2000-01, Vol.74 (2), p.987-991

2000

Volltextzugriff (PDF)

Out on the farm with DNA vaccines

Nature biotechnology, 1998-12, Vol.16 (13), p.1325-1328

1998

Volltextzugriff (PDF)

138. Potential Therapeutic Treatment of Friedrich's Ataxia Using Highly Specific Engineered Meganucleases

Molecular therapy, 2016-05, Vol.24, p.S56-S56

2016

Volltextzugriff (PDF)

394. Generation of a Novel Allogeneic CAR T Cell Platform Utilizing an Engineered Meganuclease and AAV Donor Template to Achieve Efficient Disruption of T Cell Receptor Expression and Simultaneous Homology-Directed Insertion of a CD19 CAR

Molecular therapy, 2016-05, Vol.24, p.S156-S156

2016

Volltextzugriff (PDF)

OR25-01 Durable CYP21A2 Gene Therapy in Non-Human Primates for Treatment of Congenital Adrenal Hyperplasia

Journal of the Endocrine Society, 2020-05, Vol.4 (Supplement_1)

2020

Volltextzugriff (PDF)

Design of a Phase 1/2 Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy in Adults With Classic Congenital Adrenal Hyperplasia (CAH) Due to 21-hydroxylase Deficiency Through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene

Journal of the Endocrine Society, 2021-05, Vol.5 (Supplement_1), p.A82-A82

2021

Volltextzugriff (PDF)

Analysis of early region 3 mutants of mouse adenovirus type 1

Journal of Virology, 1996-09, Vol.70 (9), p.5867-5874

1996

Volltextzugriff (PDF)

Interaction of Mouse Adenovirus Type 1 Early Region 1A Protein with Cellular Proteins pRb and p107

Virology (New York, N.Y.), 1996-10, Vol.224 (1), p.184-197

1996

Volltextzugriff (PDF)

Characterization of an 11K Protein Produced by Early Region 3 of Mouse Adenovirus Type 1

Virology (New York, N.Y.), 1995-04, Vol.208 (2), p.457-466

1995

Volltextzugriff (PDF)

Early region 4 sequence and biological comparison of two isolates of mouse adenovirus type 1

Virology (New York, N.Y.), 1991, Vol.180 (1), p.257-265

1991

Volltextzugriff (PDF)

Transcription mapping of mouse adenovirus type 1 early region 3

Virology (New York, N.Y.), 1990-03, Vol.175 (1), p.81-90

1990

Volltextzugriff (PDF)

Genome organization of mouse adenovirus type 1 early region 1: A novel transcription map

Virology (New York, N.Y.), 1989-06, Vol.170 (2), p.523-536

1989

Volltextzugriff (PDF)

One disease, two vaccines: challenges in prevention of meningococcal disease

Medical journal of Australia, 2020-06, Vol.212 (10), p.453-456.e1

2020

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(47)
magazinearticle
(2)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(25)
Animals
(20)
Humans
(17)
Virology
(15)
Mice
(14)
Female
(12)
Biological And Medical Sciences
(7)
Cell Line
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Medicine, Research & Experimental
(6)
Mice, Inbred Balb C
(6)
Microbiology
(6)
Molecular Sequence Data
(6)
Pregnancy
(6)
Research & Experimental Medicine
(6)
Vaccines
(6)
Base Sequence
(5)
Alphavirus
(4)
Amino Acid Sequence
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Nonviral delivery of self-amplifying RNA vaccines

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice

Optimized AAV Vectors for TMC1 Gene Therapy in a Humanized Mouse Model of DFNB7/11

Control of alphavirus-based gene expression using engineered riboswitches

Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells

Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice

Ribosomal Protein S6 Associates with Alphavirus Nonstructural Protein 2 and Mediates Expression from Alphavirus Messages

Production of recombinant adeno-associated virus 5 using a novel self-attenuating adenovirus production platform

A two-phase innate host response to alphavirus infection identified by mRNP-tagging in vivo

Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity

Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization

Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus

Out on the farm with DNA vaccines

138. Potential Therapeutic Treatment of Friedrich's Ataxia Using Highly Specific Engineered Meganucleases

394. Generation of a Novel Allogeneic CAR T Cell Platform Utilizing an Engineered Meganuclease and AAV Donor Template to Achieve Efficient Disruption of T Cell Receptor Expression and Simultaneous Homology-Directed Insertion of a CD19 CAR

OR25-01 Durable CYP21A2 Gene Therapy in Non-Human Primates for Treatment of Congenital Adrenal Hyperplasia

Analysis of early region 3 mutants of mouse adenovirus type 1

Interaction of Mouse Adenovirus Type 1 Early Region 1A Protein with Cellular Proteins pRb and p107

Characterization of an 11K Protein Produced by Early Region 3 of Mouse Adenovirus Type 1

Early region 4 sequence and biological comparison of two isolates of mouse adenovirus type 1

Transcription mapping of mouse adenovirus type 1 early region 3

Genome organization of mouse adenovirus type 1 early region 1: A novel transcription map

One disease, two vaccines: challenges in prevention of meningococcal disease

Suchergebnisse filtern